Skip to content

Acute Myeloid Leukemia With Bcr Abl1 C4329268

Published: July 22, 2026Updated: August 20, 2026

A rare form of acute myeloid leukemia that has the Philadelphia chromosome (BCR-ABL1), more commonly associated with chronic myeloid leukemia. It typically affects adults and requires specialized treatment approaches. Management often involves targeted therapy combined with chemotherapy.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
C92.62, C92.61
ICD-11
2A00.0
Body system
hematologic
Severity
critical
Chronic
false

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Generalized symptoms

Symptoms may be severe and require urgent medical attention.

Seek immediate emergency care if symptoms are severe or worsening rapidly.

Fatigue

(hematologic)

Fever

(hematologic)

Easy bruising

(hematologic)

Bone pain

(hematologic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Image-guided procedure with follow-up care

Requires immediate emergency medical intervention. Do not delay treatment.

procedure
2

Tyrosine Kinase Inhibitor Combination

BCR-ABL1 targeted therapy combined with hypomethylating agents or low-dose chemotherapy, particularly for elderly or unfit patients.

medication
3

Allogeneic Stem Cell Transplant

Potentially curative treatment option for eligible patients, especially those with poor response to TKI-based therapy or high-risk features.

procedure

Additional treatment options

Ponatinib for T315I Mutation

Third-generation TKI specifically indicated for Philadelphia chromosome-positive leukemias with the T315I gatekeeper mutation.

medication

Intensive Chemotherapy with TKI

Standard induction chemotherapy for fit patients with addition of a TKI, followed by consolidation and maintenance.

medication

Chronic Illness Counseling

Psychological support addressing the chronic nature of Ph+ AML, treatment duration, and potential for long-term TKI therapy.

psychological

When to seek medical help

Recognize when you need immediate medical attention.

Call emergency services (911) immediately

!

Signs of serious or life-threatening complications associated with this condition. Immediate medical evaluation is required.

Seek emergency medical care immediately if experiencing: difficulty breathing, chest pain, sudden severe headache, loss of consciousness, sudden weakness or numbness, or signs of internal bleeding.

Frequently asked questions

Common questions about this topic.

Q

What is Acute Myeloid Leukemia With Bcr Abl1 C4329268?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Döhner H, Estey EH, Amadori S, et al. Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel. Blood. 2017.

guideline2017View source →
2

Klein SA, Ballin C, Schlenk RF. BCR-ABL1-positive acute myeloid leukemia: a distinct entity? Haematologica. 2020.

review2020
3

Pigneux A, Bouchard S, Larosa F, et al. Tyrosine kinase inhibitor combined with chemotherapy in AML with BCR-ABL1: a phase II study. J Clin Oncol. 2022.

clinical_trial2022
4

Liu J, Zhang M, Chen W, Wang N. Outcomes of BCR-ABL1-positive acute myeloid leukemia: systematic review and meta-analysis. Leukemia. 2023.

meta_analysis2023

Medication Comparisons

Compare medications used to treat Acute Myeloid Leukemia With Bcr Abl1 C4329268. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy